![Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes - ScienceDirect Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525157817302593-figs4.jpg)
Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes - ScienceDirect
![Frontiers | Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt–Hogg–Dubè Syndrome Family Frontiers | Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt–Hogg–Dubè Syndrome Family](https://www.frontiersin.org/files/Articles/835346/fonc-12-835346-HTML/image_m/fonc-12-835346-g001.jpg)
Frontiers | Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt–Hogg–Dubè Syndrome Family
![Genes | Free Full-Text | Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer Genes | Free Full-Text | Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer](https://www.mdpi.com/genes/genes-14-01530/article_deploy/html/images/genes-14-01530-g001.png)
Genes | Free Full-Text | Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer
![New scheme to routinely test patients for inherited cancer genes | Leaders in Pharmaceutical Business Intelligence (LPBI) Group New scheme to routinely test patients for inherited cancer genes | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://pharmaceuticalintelligence.com/wp-content/uploads/2021/06/article-7.3.7.-new-scheme-to-routinely-test-patients-for-inherited-cancer-genes-1.png)
New scheme to routinely test patients for inherited cancer genes | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Cancers | Free Full-Text | Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing Cancers | Free Full-Text | Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing](https://pub.mdpi-res.com/cancers/cancers-14-01434/article_deploy/html/images/cancers-14-01434-sch001.png?1646972610)
Cancers | Free Full-Text | Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
![PDF) Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer PDF) Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer](https://i1.rgstatic.net/publication/312081774_Benchmarking_of_Whole_Exome_Sequencing_and_Ad_Hoc_Designed_Panels_for_Genetic_Testing_of_Hereditary_Cancer/links/587208c708ae6eb871c433a1/largepreview.png)